| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6191131 | European Journal of Surgical Oncology (EJSO) | 2015 | 7 Pages |
Abstract
In our population-based study, the use of metformin was associated with an improved overall and distant metastasis-free survival rate in patients with oesophageal cancer. These data are complementary to one other clinical study and warrant further prospective study.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
L. Van De Voorde, L. Janssen, R. Larue, R. Houben, J. Buijsen, M. Sosef, B. Vanneste, M.-C. Schraepen, M. Berbée, P. Lambin,